Senseonics to Participate in the Jefferies Healthcare Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Jefferies Healthcare Conference in New York, NY.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Thursday, May 26, 2022
Information
Tags: 
Diabetes, Health, Medical Devices, Diabetes, Skin, CGM, Conference, SENS, XL, Interest, NYSE, Technology, Medical device
Geotags: 
NEW YORK, MARYLAND, UNITED STATES, NORTH AMERICA, NY
⚠ generated by AI ↴
Organisation: 
SENSEONICS
Stock Symbol: 
NYSEAM:SENS
Summary
Key Points: 
  • Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Jefferies Healthcare Conference in New York, NY.
  • Interested parties may access a live and recorded webcast of the presentation on the Investor Relations section of the companys website at www.senseonics.com .
  • Senseonics Holdings, Inc. (Senseonics) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology.
  • Senseonics' CGM systems, Eversense, Eversense XL and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor.


Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Jefferies Healthcare Conference in New York, NY.

Management is scheduled to present on Thursday, June 9, 2022 at 1:30pm ET. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

Copyright: 
Copyright Business Wire 2022